Counterfeit medicines not only infringe IP rights, including trademarks and patents, but also pose grave threats to public health, endangering the lives of patients globally.
In this session, we will examine the impact that counterfeit medicines have on public health, as well as on the pharmaceutical industry, which is one of the most innovative and research-intensive sectors.
Furthermore, we will explore collaborative international efforts, namely Operation Pangea led by INTERPOL, aimed at combating the global production, distribution, and sale of counterfeit medicines.
1:00 – 1:05 p.m.
Welcoming remarks and introduction of the speakers
1:05 – 1:25 p.m.
Counterfeit medicines: IP infringement and public health concerns
1:25 – 1:45 p.m.
International operations to combat trade in counterfeit medicines
1:45 – 2:00 p.m.
Questions and Answers
Director of Industrial Property and Legal and International Affairs, Mexican Association of Pharmaceutical of Pharmaceutical Research Industries, Mexico
Coordinator, Public Health & Pharmaceutical Crime, Illicit Goods and Global Health Programme, INTERPOL